The molecular design of biologically active derivatives of N-phenylanthranilic acid

Authors

  • O. M. Svechnikova Kharkiv National Pedagogical University named after G.S.Skovoroda, Ukraine
  • S. V. Kolisnyk National University of Pharmacy, Ukraine
  • O. F. Vinnyk Kharkiv National Pedagogical University named after G.S.Skovoroda, Ukraine
  • T. A. Kostina National University of Pharmacy, Ukraine
  • T. V. Zhukova National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/ophcj.18.937

Keywords:

substituted N-phenylanthranilic acids, anti-inflammatory activity

Abstract

Most QSAR methods are based on determination of dependence of different types of biological activity of compounds on their physicochemical parameters, which determination is experimentally quite difficult, while those compounds that are calculated theoretically often have systematic deviations.
Aim. To determine the increments of substituents in isostructural series of hydrazides and thiosemicarbazides of substituted N-phenylanthranilic acids for their anti-inflammatory activity by the empirical method on the de nova model.
Results and discussion. The study was conducted for 18 thiosemicarbazide (batch 1) and 15 hydrazides (batch 2) of substituted N-phenylanthranilic acid. The increments calculated show that introduction of substituents in the anthranilic moiety of the thiosemicarbazide molecule increases the anti-inflammatory activity. The increments of substituents in the non-anthranilic fragment of the molecule have different signs and values, depending on the nature and position of the radical. Introduction of substituents (Cl-, NO2-) into the para-position of the anthranilic fragment of the molecule of N-phenylantranilic acid hydrazide increases the anti-inflammatory activity, while introduction of various substituents into the non-anthranilic fragment of the molecule causes both an increase and a decrease in lg P.
Experimental part. The study of the anti-inflammatory activity was performed on the “formalin edema” model in rats using the oncometric method. The substances were administered orally in the form of a fine suspension stabilized by the emulsifier Tween-80 in the doses of 50 mg/kg of the animal body weight. The reference drug indomethacin was administered in the dose of 50 mg/kg.
Conclusions. The increments of substituents in isostructural series of hydrazides and thiosemicarbazides of substituted N-phenylanthranilic acids have been determined by the empirical method. The dependence of the increments on the nature and position of substituents in molecules has been analyzed.

Downloads

Download data is not yet available.

References

  1. Free, S. M., Wilson, J. W. (1964). A Mathematical Contribution to Structure–Activity Studies. Journal of Medicinal Chemistry, 7 (4), 395–399. doi:
  2. 1021/jm00334a001
  3. Craig, R. H. (1972). Structure–antibacterial activity relationships of 2–phenyl–quinoline–4–carbynols. J. Pharm. Sci., 61 (4), 423–428.
  4. Smithfield, W. R., Purcell, W. D. (1967). Relation between chemical structure and pharmaceutical activity of pyperidinsulfamoil substituted thiosemicarbazide.
  5. J. Pharm. Sci., 56 (6), 557–579.
  6. Bulatova, Z. M., Lymarev, P. S., Osmonalieva, T. T. et al. (2012). Vestnik KazNU. Seriia Biologicheskaia, 1(53), 27–29.
  7. Ivanov, V. V., Sleta, L. A., Tolstaia, A. A. (2003). Zhurnal organicheskoi i farmatcevticheskoi khimii, 2, (4 (8)), 66–68.
  8. Drozhzhyna, N. A. (2004). Vestnik Rossiiskogo universiteta druzhby narodov. Seriia: Meditcina, 2 (26), 96–101.
  9. Gazaliev, A. M., Zhurigenov, M. Zh., Fazylov, S. D. (1992) Novye fosforproizvodnye efedrinovykh alkaloidov. Almaty: Gylym, 176.
  10. Navdeep, S. S. (2012). Review on Computational Methods in Developing Quantitative Structure–Activity Relationships (QSAR). Journal of Drug
  11. Design and Discovery, 3 (3), 815–836.
  12. Rudenko, V. M. (2012). Matematychna statystyka. Kyiv: Tsentr uchbovoi lіteratury, 304.
  13. Mokhort, N. A., Riabukha, T. K. (1971). Patologicheskaia fiziologiia i eksperimentalnaia terapiia, 15 (2), 100–102.
  14. Derzhavna farmakopeia Ukrainy. (2001). Kharkiv: RIREH, 1, 556.

Downloads

Published

2018-03-14

How to Cite

(1)
Svechnikova, O. M.; Kolisnyk, S. V.; Vinnyk, O. F.; Kostina, T. A.; Zhukova, T. V. The Molecular Design of Biologically Active Derivatives of N-Phenylanthranilic Acid. J. Org. Pharm. Chem. 2018, 16, 49-53.

Issue

Vol. 16 No. 1(61) (2018)

Section

Original Researches

License

Copyright (c) 2018 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:

1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.

3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).